These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23819487)

  • 21. Detecting and treating retinopathy in patients with type I diabetes mellitus. A health policy model.
    Javitt JC; Canner JK; Frank RG; Steinwachs DM; Sommer A
    Ophthalmology; 1990 Apr; 97(4):483-94; discussion 494-5. PubMed ID: 2109299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Screening for diabetic retinopathy].
    Hartstra WW; Holleman F; Hoekstra JB; Schlingemann RO
    Ned Tijdschr Geneeskd; 2007 Jan; 151(4):228-33. PubMed ID: 17323877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First Incidence and Progression Study for Diabetic Retinopathy in Portugal, the RETINODIAB Study: Evaluation of the Screening Program for Lisbon Region.
    Dutra Medeiros M; Mesquita E; Gardete-Correia L; Moita J; Genro V; Papoila AL; Amaral-Turkman A; Raposo JF
    Ophthalmology; 2015 Dec; 122(12):2473-81. PubMed ID: 26383994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for diabetic retinopathy.
    Owens DR; Dolben J; Young S; Ryder RE; Jones IR; Vora J; Jones D; Morsman D; Hayes TM
    Diabet Med; 1991; 8 Spec No():S4-10. PubMed ID: 1825956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The incidence of diabetic retinopathy on a set of 10,000 patients with diabetes mellitus].
    Ignat F; Damian C; Davidescu L; Costache D; Jitianu B
    Oftalmologia; 2002; 54(3):44-7. PubMed ID: 12723197
    [No Abstract]   [Full Text] [Related]  

  • 26. Screening for diabetic retinopathy in James Bay, Ontario: a cost-effectiveness analysis.
    Maberley D; Walker H; Koushik A; Cruess A
    CMAJ; 2003 Jan; 168(2):160-4. PubMed ID: 12538543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis.
    Thomas RL; Dunstan F; Luzio SD; Roy Chowdury S; Hale SL; North RV; Gibbins RL; Owens DR
    BMJ; 2012 Feb; 344():e874. PubMed ID: 22362115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visual acuity in a population with regular screening for type 2 diabetes mellitus and eye disease.
    Olafsdottir E; Andersson DK; Stefánsson E
    Acta Ophthalmol Scand; 2007 Feb; 85(1):40-5. PubMed ID: 17244208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of diabetic retinopathy in patients with recently diagnosed diabetes mellitus.
    Lee KM; Sum WM
    Clin Exp Optom; 2011 Jul; 94(4):371-5. PubMed ID: 21323731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid assessment of avoidable blindness and diabetic retinopathy in Chiapas, Mexico.
    Polack S; Yorston D; López-Ramos A; Lepe-Orta S; Baia RM; Alves L; Grau-Alvidrez C; Gomez-Bastar P; Kuper H
    Ophthalmology; 2012 May; 119(5):1033-40. PubMed ID: 22342012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prevalence and severity of diabetic retinopathy, associated risk factors and vision loss in patients registered with type 2 diabetes in Luganville, Vanuatu.
    Smith TS; Szetu J; Bourne RR
    Br J Ophthalmol; 2007 Apr; 91(4):415-9. PubMed ID: 17077115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diabetic retinopathy in type 1 diabetics in the county of Frederiksborg].
    Jacobsen N; Kjer BE; Goldschmidt E; Andersen OO; Thorsteinsson B
    Ugeskr Laeger; 2003 Jul; 165(30):2953-6. PubMed ID: 12926196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ten Emerging Trends in the Epidemiology of Diabetic Retinopathy.
    Sabanayagam C; Yip W; Ting DS; Tan G; Wong TY
    Ophthalmic Epidemiol; 2016 Aug; 23(4):209-22. PubMed ID: 27355693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinopathy screening in individuals with type 2 diabetes: who, how, how often, and at what cost--an epidemiologic review.
    Swanson M
    Optometry; 2005 Nov; 76(11):636-46. PubMed ID: 16298316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biennial eye screening in patients with diabetes without retinopathy: 10-year experience.
    Olafsdóttir E; Stefánsson E
    Br J Ophthalmol; 2007 Dec; 91(12):1599-601. PubMed ID: 17627978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Four-Year Screening Interval and Vision-Threatening Retinopathy in Type 2 Diabetes Patients With Good Glycemic Control.
    Tsujimoto T; Kajio H
    Mayo Clin Proc; 2021 Feb; 96(2):322-331. PubMed ID: 33549254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction models for development of retinopathy in people with type 2 diabetes: systematic review and external validation in a Dutch primary care setting.
    van der Heijden AA; Nijpels G; Badloe F; Lovejoy HL; Peelen LM; Feenstra TL; Moons KGM; Slieker RC; Herings RMC; Elders PJM; Beulens JW
    Diabetologia; 2020 Jun; 63(6):1110-1119. PubMed ID: 32246157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of screening in preventing blindness due to diabetic retinopathy.
    Arun CS; Ngugi N; Lovelock L; Taylor R
    Diabet Med; 2003 Mar; 20(3):186-90. PubMed ID: 12675661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for diabetic retinopathy: new perspectives and challenges.
    Vujosevic S; Aldington SJ; Silva P; Hernández C; Scanlon P; Peto T; Simó R
    Lancet Diabetes Endocrinol; 2020 Apr; 8(4):337-347. PubMed ID: 32113513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening and prevention of diabetic blindness.
    Stefánsson E; Bek T; Porta M; Larsen N; Kristinsson JK; Agardh E
    Acta Ophthalmol Scand; 2000 Aug; 78(4):374-85. PubMed ID: 10990036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.